1887
Volume 2023, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: Healthcare-associated infections (HAI) in critical patients affect the quality and safety of patient care as they impact morbidity and mortality. During the COVID-19 pandemic, an increase in the incidence rate was reported worldwide. We aim to describe the incidence of HAI in the intensive care unit (ICU) during a 10-year follow-up period and compare the incidence during the pre-COVID-19 and COVID-19 periods.

Methods: A retrospective observational study of HAI in the medical-surgical ICU at The Cuban Hospital was conducted. The data collected include the annual incidence of HAI, its etiology, and antimicrobial resistance, using the Centers for Disease Control and Prevention definitions, except for other respiratory tract infections (RTIs).

Results: A total of 155 patients had HAI, of which 130 (85.5%) were identified during COVID-19. The frequency of device-associated infections (DAI) and non-DAI was higher during COVID-19, except for infections. Etiology was frequently related to species of , , and in both periods, and a higher frequency of , , , , , and was noted during the COVID-19 period. Device utilization ratio increased by 10.7% for central lines and 12.9% for ventilators, while a reduction of 15% in urinary catheter utilization ratio was observed. DAI incidence was higher during the COVID-19, with a 2.79 higher risk of infection (95% CI: 0.93–11.21; < 0.0050), 15.31 (2.53–625.48), and 3.25 (0.68–31.08) for CLABSI, VAP, and CAUTI, respectively.

Conclusion: The incidence of DAI increased during the pandemic period as compared to the pre-pandemic period, and limited evidence of the impact on antimicrobial resistance was observed. The infection control program should evaluate strategies to minimize the impact of pandemics on HAI.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2023.11
2023-04-28
2024-05-30
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2023/1/qmj.2023.11.html?itemId=/content/journals/10.5339/qmj.2023.11&mimeType=html&fmt=ahah

References

  1. Al-Tawfiq JA, Tambyah PA. Healthcare-associated infections (HAI) perspectives. J Infect Public Health. 2014 Jul–Aug;7:(4):339–44. doi: 10.1016/j.jiph.2014.04.003.
    [Google Scholar]
  2. Joint Commission International Accreditation Standards for Hospitals , 7th Edition. Joint Commission Resources, 2020. ISBN (print): 978-1-63585-148-9.
    [Google Scholar]
  3. Weiner-Lastinger LM, Pattabiraman V, Konnor RY, Patel PR, Wong E, Xu SY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2022 Jan;43:(1):12–25. doi: 10.1017/ice.2021.362.
    [Google Scholar]
  4. Ali HS, Khan FY, George S, Shaikh N, Al-Ajmi J. Epidemiology and outcome of ventilator-associated pneumonia in a heterogeneous ICU population in Qatar. Biomed Res Int. 2016;2016:):8231787. doi: 10.1155/2016/8231787.
    [Google Scholar]
  5. Gupta P, Thomas M, Patel A, George R, Mathews L, Alex S, et al. Bundle approach used to achieve zero central line-associated bloodstream infections in an adult coronary intensive care unit. BMJ Open Qual. 2021 Feb;10:(1):e001200. doi: 10.1136/bmjoq-2020-001200.
    [Google Scholar]
  6. Rosenthal VD, Myatra SN, Divatia JV, Biswas S, Shrivastava A, Ruzzieh MAA, et al. The impact of COVID-19 on healthcare-associated infections in intensive care units in low- and middle-income countries: International Nosocomial Infection Control Consortium (INICC) findings. Int J Infect Dis. 2022 May;118::83–8. doi: 10.1016/j.ijid.2022.02.041.
    [Google Scholar]
  7. McMullen KM, Smith BA, Rebmann T. Impact of SARS-CoV-2 on hospital acquired infection rates in the United States: predictions and early results. Am J Infect Control. 2020 Nov;48:(11):1409–11. doi: 10.1016/j.ajic.2020.06.209.
    [Google Scholar]
  8. Baccolini V, Migliara G, Isonne C, Dorelli B, Barone LC, Giannini D, et al. The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study. Antimicrob Resist Infect Control. 2021 Jun 4;10:(1):87. doi: 10.1186/s13756-021-00959-y.
    [Google Scholar]
  9. Baker MA, Sands KE, Huang SS, Kleinman K, Septimus EJ, Varma N, et al.; CDC Prevention Epicenters Program. The impact of COVID-19 on healthcare-associated infections. Clin Infect Dis. 2021 Aug;9::ciab688. doi: 10.1093/cid/ciab688.
    [Google Scholar]
  10. Fakih MG, Bufalino A, Sturm L, Huang RH, Ottenbacher A, Saake K, et al. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol. 2022 Jan;43:(1):26–31. doi: 10.1017/ice.2021.70.
    [Google Scholar]
  11. Bardi T, Pintado V, Gomez-Rojo M, Escudero-Sanchez R, AzzamLopez A, Diez-Remesal Y, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis. 2021 Mar;40:(3):495–502. doi: 10.1007/s10096-020-04142-w.
    [Google Scholar]
  12. Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al.; COVID-19 Researchers Group. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021 Jan;27:(1):83–8. doi: 10.1016/j.cmi.2020.07.041.
    [Google Scholar]
  13. Baddley JW, Thompson GR 3rd, Chen SC, White PL, Johnson MD, Nguyen MH, et al. Coronavirus disease 2019-associated invasive fungal infection. Open Forum Infect Dis. 2021 Nov 16;8:(12):ofab510. doi: 10.1093/ofid/ofab510.
    [Google Scholar]
  14. Intra J, Sarto C, Beck E, Tiberti N, Leoni V, Brambilla P. Bacterial and fungal colonization of the respiratory tract in COVID-19 patients should not be neglected. Am J Infect Control. 2020 Sep;48:(9):1130–1. doi: 10.1016/j.ajic.2020.06.185.
    [Google Scholar]
  15. Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021 Jan 4;190:(1):161–75. doi: 10.1093/aje/kwaa191.
    [Google Scholar]
  16. Alajmi J, Jeremijenko AM, Abraham JC, Alishaq M, Concepcion EG, Butt AA, et al. COVID-19 infection among healthcare workers in a national healthcare system: the Qatar experience. Int J Infect Dis. 2020 Nov;100::386–9. doi: 10.1016/j.ijid.2020.09.027.
    [Google Scholar]
  17. Barman M, Tanweer H, Hatem A, Memom NI, Muhammad S, Harman TS, et al. Embracing healthcare delivery challenges during a pandemic: review from a nodal designated COVID-19 center in Qatar. Avicenna. 2021;2021:(2):8. doi: 10.5339/avi.2021.8.
    [Google Scholar]
  18. CDC/NHSN Surveillance Definitions for Specific Types of Infections . National Healthcare Safety Network (NHSN). Patient Safety Component Manual. January 2021. [cited 2021 December 18]. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf
    [Google Scholar]
  19. Rosenthal VD, Duszynska W, Ider BE, Gurskis V, Al-Ruzzieh MA, Myatra SN, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013–2018, adult and pediatric units, device-associated module. Am J Infect Control. 2021 Oct;49:(10):1267–74. doi: 10.1016/j.ajic.2021.04.077.
    [Google Scholar]
  20. Dudeck MA, Weiner LM, Allen-Bridson K, Malpiedi PJ, Peterson KD, Pollock DA, et al. National Healthcare Safety Network (NHSN) report, data summary for 2012, device-associated module. Am J Infect Control. 2013 Dec;41:(12):1148–66. doi: 10.1016/j.ajic.2013.09.002.
    [Google Scholar]
  21. Dudeck MA, Edwards JR, Allen-Bridson K, Gross C, Malpiedi PJ, Peterson KD, et al. National Healthcare Safety Network report, data summary for 2013, device-associated module. Am J Infect Control. 2015 Mar 1;43:(3):206–21. doi: 10.1016/j.ajic.2014.11.014.
    [Google Scholar]
  22. Gaid E, Assiri A, McNabb S, Banjar W. Device-associated nosocomial infection in general hospitals, Kingdom of Saudi Arabia, 2013–2016. J Epidemiol Glob Health. 2018 Mar;7:(Suppl 1):S35–40. doi: 10.1016/j.jegh.2017.10.008.
    [Google Scholar]
  23. Rebmann T, Alvino RT, Holdsworth JE. Availability and crisis standards of care for personal protective equipment during fall 2020 of the COVID-19 pandemic: A national study by the APIC COVID-19 task force. Am J Infect Control. 2021 Jun;49:(6):657–62. doi: 10.1016/j.ajic.2021.03.015.
    [Google Scholar]
  24. Huang F, Armando M, Dufau S, Florea O, Brouqui P, Boudjema S. COVID-19 outbreak and healthcare worker behavioural change toward hand hygiene practices. J Hosp Infect. 2021 May;111::27–34. doi: 10.1016/j.jhin.2021.03.004.
    [Google Scholar]
  25. Rouzé A, Martin-Loeches I, Povoa P, Makris D, Artigas A, Bouchereau M, et al.; coVAPid Study Group. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021 Feb;47:(2):188–98. doi: 10.1007/s00134-020-06323-9.
    [Google Scholar]
  26. Rouzé A, Nseir S. Hospital-acquired pneumonia/ventilator-associated pneumonia and ventilator-associated tracheobronchitis in COVID-19. Semin Respir Crit Care Med. 2022 Apr;43:(2):243–7. doi: 10.1055/s-0041-1740334.
    [Google Scholar]
  27. Rosenthal VD, Bat-Erdene I, Gupta D, Rajhans P, Myatra SN, Muralidharan S, et al. Six-year study on peripheral venous catheter-associated BSI rates in 262 ICUs in eight countries of South-East Asia: International Nosocomial Infection Control Consortium findings. J Vasc Access. 2021 Jan;22:(1):34–41. doi: 10.1177/1129729820917259.
    [Google Scholar]
  28. Guembe M, Pérez-Granda MJ, Capdevila JA, Barberán J, Pinilla B, Martín-Rabadán P, et al.; NUVE Study Group. Nationwide study on peripheral-venous-catheter-associated-bloodstream infections in internal medicine departments. J Hosp Infect. 2017 Nov;97:(3):260–6. doi: 10.1016/j.jhin.2017.07.008.
    [Google Scholar]
  29. Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021 Apr;57:(4):106324. doi: 10.1016/j.ijantimicag.2021.106324.
    [Google Scholar]
  30. Janniger EJ, Kapila R. Public health issues with Candida auris in COVID-19 patients. World Med Health Policy. 2021 Dec;13:(4):766–72. doi: 10.1002/wmh3.472.
    [Google Scholar]
  31. Salah H, Sundararaju S, Dalil L, Salameh S, Al-Wali W, Tang P, et al. Genomic epidemiology of Candida auris in Qatar reveals hospital transmission dynamics and a South Asian origin. J Fungi (Basel). 2021 Mar 23;7:(3):240. doi: 10.3390/jof7030240.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2023.11
Loading
/content/journals/10.5339/qmj.2023.11
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error